$WLKP

Westlake Chemical Partners LP Q2 2026 Earnings Call Summary

Westlake Chemical Partners LP reported stable sequential net income of $14 million and a $3 million year-over-year increase in distributable cash flow, citing higher volumes and lower maintenance costs. The partnership renewed revolver agreements through 2031 with a 10 bp interest-rate reduction, expects fixed-margin ethylene to limit volatility, and plans to sustain distributions without new capital markets.

Original reporting
Published Aug 6, 2026, 11:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 11:56 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Westlake Chemical Partners LP Q2 2026 Earnings Call Summary — source image
Decision brief

The 30-second read

$WLKPBullishMed
01

Why it matters

Key disclosed items are stable net income, higher distributable cash flow year-over-year, revolver renewal through 2031 with a 10-basis-point rate reduction, and an improved trailing-12-month coverage ratio to 1.04x. These collectively inform distribution durability and financing risk, but the article provides no new guidance numbers beyond qualitative outlook and modeling assumptions.

02

Market read

Traders can update expectations for distribution coverage and financing cost trajectory based on the revolver rate reduction and coverage ratio improvement, though the outlook remains largely qualitative.

03

What to watch

The summary does not quantify sensitivity to volume changes, counterparty performance under the fixed-margin agreement, or potential timing of future maintenance turnarounds beyond the stated 2026 modeling assumption.

Relevance 6/10Novelty 5/10Timing: earnings call summary published pre-market today

Background

The piece summarizes Westlake Chemical Partners LP’s Q2 2026 earnings call, focusing on fixed-margin ethylene economics, distributable cash flow, and capital structure.

Company-level read

Ticker impact

$WLKPBullishMedium confidence
Context

Westlake Chemical Partners renewed revolver agreements through 2031 and secured a 10-basis-point interest-rate reduction, impacting financing costs and cash flow.

Expected impact

Mildly positive bias for distribution sustainability; likely limited upside unless margins or volumes surprise.

Evidence & confidence

The article highlights a specific refinancing benefit (10 bps) and conservative leverage (~1x), both directly tied to cash flow/distribution coverage.

Market effects

Reinforces the value of fixed-margin ethylene structures for insulating petrochemical cash flows from regional price volatility.

No specific regional demand shock is disclosed; emphasis is on Middle East-driven volatility being largely hedged via fixed margins.

Middle East price volatility is referenced, but the partnership claims insulation through fixed-margin economics.

Counterpoint

Fixed-margin insulation may reduce upside participation if ethylene margins widen, limiting distribution growth beyond current levels.

Key entities

  • Westlake Chemical Partners LP

    Partnership discussed fixed-margin ethylene sales agreement, distributable cash flow, revolver renewal, and distribution coverage.

  • Westlake Corporation

    Parent company referenced as the key driver for long-term contract extensions via OpCo ethylene supply.

  • Johnathan Marks

    Named as CFO following Steve Bender’s retirement, cited as continuity in financial leadership.

Related articles

$WLKPMed

Westlake Chemical Partners LP (WLKP): Results of Operations and Financial Condition

Westlake Chemical Partners LP (WLKP) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex991_20260630earningsrele.htm EX-99.1 Document EXHIBIT 99.1 WESTLAKE CHEMICAL PARTNERS LP Contact—(713) 585-2900 Investors—Jonathan Baksht Media—L. Benjamin Ederington Westlake Chemical Partners LP Announces Second Quarter 2026 Results • Declared quarterly distribution

$WLKPMedAI 8/10

Westlake Chemical Partners LP Announces Second Quarter 2026 Results

Westlake Chemical Partners LP (NYSE: WLKP) reported Q2 2026 net income attributable to the partnership of $14.2 million, or $0.40 per limited partner unit, versus $14.6 million in Q2 2025. Operating cash flow was $129.8 million. It declared a $0.4714 per unit distribution, 48th consecutive quarter, with trailing twelve-month coverage of 1.04x. Credit facilities were amended to extend maturities to July 2031.

$KDMed

Kyndryl Q1 Earnings Call Highlights

Kyndryl (NYSE:KD) Q1 call said demand is rising for AI deployment, hybrid modernization, cybersecurity and data-residency. It reported 40 deals worth over $50M in 12 months, with 10 in Q1, and Kyndryl Consult signings up 50%. IBM relationship changes are expected to weigh on constant-currency revenue through FY2027. FCF was -$401M; cash $2.1B. Outlook FY2027 reaffirmed.

$KAIMedAI 8/10

Kadant Q2 Earnings Call Highlights

Kadant (NYSE:KAI) reported Q2 equipment backlog of $182 million and said aftermarket demand stayed at record or near-record levels. Flow Control revenue rose 5% to $100 million; Industrial Processing revenue rose to a record $144 million; Material Handling bookings were $73 million. Q2 gross margin fell to 43.8%. Kadant raised FY revenue guidance to $1.19-$1.21B and adjusted EPS to $12.43-$12.68.

$KRPMed

Kimbell Royalty Q2 Earnings Call Highlights

Kimbell Royalty (NYSE:KRP) reported record Q2 adjusted EBITDA of $84.9 million, with cash G&A of $5.9 million ($2.50 per BOE). It declared a $0.47 per common unit cash distribution, up 15% QoQ, and said 47% may be return of capital. The borrowing base rose to $660 million; debt was $478.7 million. Rig activity and production varied by basin.

$KMPRMed

Kemper Q2 Earnings Call Highlights

Kemper (NYSE:KMPR) reported Q2 results and discussed credit-loss allowances tied to surplus notes in its reciprocal exchange, including a $21 million pre-tax charge on $36 million of notes. Holding-company liquidity was $766 million and debt-to-capital rose to 28.3%. Personal auto normalized combined ratio was 102% and commercial 93.7%, with California rate actions and restructuring savings over $80 million run-rate.